HopeStage
Back to all studies
CompletedNCT00025792

Pramipexole added to mood stabilizers for bipolar depression

About this title

Clinical Trial of Pramipexole in Bipolar Depression

Read the official source — NCT00025792
Medication studyUnited StatesBipolarity
The study in practice

Understand this study

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2001
Recruitment status
Completed
Enrollment listed in the registry
200
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT00025792
Official title
Show the full official title

An Investigation of the Antidepressant Efficacy of a Dopamine Agonist With Neurotrophic Properties in Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Pramipexole.

Want to explore more studies?

Explore studies